Skip to content

Clinical trials

Active, not recruiting Carcinoma, Renal Cell trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Renal Cell Status: Active, not recruiting Country / region: South Korea Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20161
20171
20192
20201
20213
20225
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting17

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC5
AstraZeneca3
Hoffmann-La Roche2
Bayer1
EMD Serono Research & Development Institute, Inc.1
Eisai Inc.1
Exelixis1
Genentech, Inc.1
GlaxoSmithKline1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Renal Cell17
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Kidney Neoplasms4
Melanoma4
Carcinoma3
Neoplasms3
Ovarian Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Breast Neoplasms2

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.